搜索筛选:
搜索耗时1.5135秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
类      型:
[期刊论文] 作者:Hongliang Kong,Zhanquan Li,Shu, 来源:中国神经再生研究:英文版 年份:2010
BACKGROUND: Transplantation of Akt-over-expressing mesenchymal stem cells (Akt-MSCs) has been shown to repair infarcted myocardium and improve cardiac function....
[期刊论文] 作者:Hongliang Kong,Zhanquan Li,Shu, 来源:中国神经再生研究(英文版) 年份:2004
BACKGROUND: Transplantation of Akt-over-expressing mesenchymal stem cells (Akt-MSCs) has been shown to repair infarcted myocardium and improve cardiac function....
[期刊论文] 作者:Hongliang Kong,Zhanquan Li,Shu, 来源:中国神经再生研究(英文版) 年份:2010
BACKGROUND: Transplantation of Akt-over-expressing mesenchymal stem cells (Akt-MSCs) has been shown to repair infarcted myocardium and improve cardiac function....
[会议论文] 作者:Hongliang Kong,Zhanquan Li,Long Yuan,Ru-ming Guan, 来源:The 22nd Great Wall International Congress of Cardiology Asi 年份:2011
[期刊论文] 作者:李波,YANG Jinyu,CHEN Zhanquan,LI Hailian,, 来源:Journal of Wuhan University of Technology(Materials Science) 年份:2016
We investigated microstructure morphologies of three asphalts(SK, Karamay, and Esso) used in China using atomic force microscopy(AFM). The topography and phase...
[会议论文] 作者:Hongliang Kong,Zhanquan Li,Long Yuan,Ru-ming Guan, 来源:The 22nd Great Wall International Congress of Cardiology Asi 年份:2011
[期刊论文] 作者:LI Bo,YANG Jinyu,CHEN Zhanquan,LI Hailian, 来源:武汉理工大学学报(材料科学版)(英文版) 年份:2016
[会议论文] 作者:Zhanquan Li,Li Liu,Haichang Wang,Wenyi Guo,Ming Yuan,Shuzheng Lv,Hongbin Yan,Hanjun Zhao,Suping Lang, 来源:The 22nd Great Wall International Congress of Cardiology Asi 年份:2011
[会议论文] 作者:Zhanquan Li,Haichang Wang,Shuzheng Lv,Li Liu,Wenyi Guo,Ming Yuan,Hongbin Yan,Hanjun Zhao,Suping Lang, 来源:The 22nd Great Wall International Congress of Cardiology Asi 年份:2011
[会议论文] 作者:Bo Xu,Runlin Gao,Yuejin Yang,Yelin Zhao,Jianan Wang,Shaoliang Chen,Bin Liu,Fang Chen,Zhanquan Li,Yaling, 来源:2013中国心脏大会(CHC) 年份:2013
[会议论文] 作者:Bo Xu,Runlin Gao,Jianan Wang,Yuejin Yang,Shaoliang Chen,Bin Liu,Fang Chen,Zhanquan Li,Yaling Han,Guosheng, 来源:2013中国心脏大会(CHC) 年份:2013
Background Treatment of drug-eluting stent (DES) restenosis is still challenging with no established best strategy.The PEPCAD China ISR trial was to demonstrate the efficacy and safety of paclitaxelco...
相关搜索: